NDC 0378-0197-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-0197
- Requested NDC
- 0378-0197-05
- Package NDCs from labels
- 0378-0197-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-0197-01 | EA - Each | 0378-0197 | 705c1658-2999-4e88-b00b-270645844035 | 1 | 2012-07-24 |
| 0378-0197-05 | EA - Each | 0378-0197 | 4ae28794-a74e-4ae7-bbf0-2fa45be72791 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trifluoperazine Hydrochloride | TRIFLUOPERAZINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | c2575a86-19e5-44df-8603-ff066bb9c9c5 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Phenytoin | PHENYTOIN | Mylan Pharmaceuticals Inc. | 37943ec1-a8d2-42df-967e-6f96f84c017b | 2024-12-24 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Azelastine Hydrochloride and Fluticasone Propionate | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | Mylan Pharmaceuticals Inc. | 7b5cc5a0-0d47-46b5-b5fb-eb9cc248ae9e | 2024-12-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Glucagon | GLUCAGON | Mylan Pharmaceuticals Inc. | 15b49500-0aae-4e25-9a1d-709983233cc6 | 2024-12-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate | EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE | Mylan Pharmaceuticals Inc. | d9a4185e-43fa-4aeb-9b0f-8db01b166038 | 2024-12-14 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| amlodipine besylate | AMLODIPINE BESYLATE | Mylan Pharmaceuticals Inc. | 180ee374-24f2-4b9c-9d54-8815f2b1dc9b | 2024-11-28 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Budesonide | BUDESONIDE | Mylan Pharmaceuticals Inc. | f7265276-e649-4bc4-8ac8-1f5ac2b984e8 | 2024-11-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Amlodipine and atorvastatin | AMLODIPINE AND ATORVASTATIN | Mylan Pharmaceuticals Inc. | 4be76756-4114-4d50-a36c-fd410f6c773d | 2024-11-11 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| NITROGLYCERIN | NITROGLYCERIN | Mylan Pharmaceuticals Inc. | 041f127e-5166-4484-bc1a-0a373d1187ae | 2024-10-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Nevirapine | NEVIRAPINE | Mylan Pharmaceuticals Inc. | 690da74b-2481-47fc-93ae-8340e0caf0a4 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Mylan Pharmaceuticals Inc. | 96b3e35a-e174-49cd-8695-acd7d23e7710 | 2024-10-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Phenytek | EXTENDED PHENYTOIN SODIUM | Mylan Pharmaceuticals Inc. | 0f94c791-8b07-4b41-927e-c9f28bec5f60 | 2024-10-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Mylan Pharmaceuticals Inc. | 0e98ee9b-84e9-4cd8-a3ea-1247e1a510a5 | 2024-10-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Tretinoin | TRETINOIN | Mylan Pharmaceuticals Inc. | ba377a5e-e48a-4bd9-9d76-929d70793396 | 2024-10-09 | Adverse reactions | Mylan Pharmaceuticals Inc. |
| Rivastigmine | RIVASTIGMINE | Mylan Pharmaceuticals Inc. | 4ab335d1-19ee-4cd9-9776-8086645d19e4 | 2024-09-21 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Lansoprazole | LANSOPRAZOLE | Mylan Pharmaceuticals Inc. | c8fa7401-907f-41b6-a2e1-f4bc214f2cdf | 2024-09-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Sertraline hydrochloride | SERTRALINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 1a58062b-e635-431a-908d-2651c6a4a21c | 2024-09-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Latanoprost | LATANOPROST | Mylan Pharmaceuticals Inc. | 463ecfde-5acb-4983-969d-0c0021bfbf48 | 2024-09-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Mylan Pharmaceuticals Inc. | 2837a082-3a34-6f81-5e43-45a70295686b | 2024-08-31 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Sildenafil Citrate | SILDENAFIL CITRATE | Mylan Pharmaceuticals Inc. | 98a9897b-0cbc-4ea6-9ac2-4dd719a2ede0 | 2024-08-29 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.